Junsong Zhang
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Optimization, Immunological Evaluation, and Combination Study of Mincle-Dependent Self-Adjuvanted Anti-Tn Cancer Vaccines with an External Adjuvant.
Journal: Journal of medicinal chemistry
Published: May 15, 2025
Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L.
Journal: Frontiers in microbiology
Published: February 25, 2022
A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
Journal: Signal transduction and targeted therapy
Published: November 16, 2021
USP10 regulates B cell response to SARS-CoV-2 or HIV-1 nanoparticle vaccines through deubiquitinating AID.
Journal: Signal transduction and targeted therapy
Published: July 26, 2021
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 22, 2021
Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors.
Journal: mBio
Published: January 20, 2021
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.
Journal: Immunity
Published: October 11, 2020
The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.
Journal: Signal transduction and targeted therapy
Published: September 15, 2020
Positive Feedback Loop of Long Noncoding RNA OASL-IT1 and Innate Immune Response Restricts the Replication of Zika Virus in Epithelial A549 Cells.
Journal: Journal of innate immunity
Published: August 10, 2020
Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies.
Journal: Cellular & molecular immunology
Published: July 28, 2020
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Journal: Signal transduction and targeted therapy
Published: June 23, 2020
Last Updated: 09/26/2026